Foundation for Inflammation and Olfactory Studies

To receive research funds and conduct clinical trials to study the effects of a new science called Olfactory Enrichment on the expression of symptoms from 160 diseases and conditions.

Why Olfactory Stimulation?

Olfaction (sense of smell) is the brain’s only direct “super-highway” into the memory (hippocampus) and emotional (amygdala) centers. More than any of the five senses, olfaction has an over-sized effect on memory and emotion. Olfactory Enrichment uses a large number of odorants to prevent and reverse memory loss. This is a much different science and mechanism than “aromatherapy.” All memory loss including all dementias is preceded by or accompanies olfactory loss. Memory loss comes from aging, pollution, 160 diseases and conditions, Covid-19, radiation, chemotherapy, anesthesia, ultra-processed foods and others. Then chronic inflammation occurs causing the expression of symptoms of these diseases and conditions.

The effect is so large that olfactory loss alone can predict who will develop memory loss, who will then descend into Mild Cognitive Impairment and further into dementia, like Alzheimer’s Disease. It can predict your chances of dying from all causes within 5 years after the age of 50. But Olfactory Enrichment can prevent and reverse memory and cognitive loss. It can likely prevent and reverse chronic inflammation which causes symptoms to arise from diseases.

The effects of Olfactory Enrichment has now been shown in 20 clinical trials. The seminal paper in the sector has now become the #1 paper published in Neuroscience in the last 5 years. It’s been reported in over 200 media articles.

Olfactory Enrichment is effective in children, young adults, seniors over 60 and now it is the most effective treatment for Alzheimer’s Disease known. Seniors improve by 226% over controls. Dementia including Alzheimer’s patients improve up to 300%.

These are the largest improvements in human memory ever shown.

However, there has been one significant problem in that people will not expend the energy to self-administer this manually intensive therapy. This has now been solved by automating the entire effort with the invention of a bedside device. This has been engineered over 5 years by Science Lab 3 Inc., a spinout company from the Department of Neurobiology, Behavior and Memory at the University of California Irvine. Proposed research will use this newly automated delivery system. 

With it, research studies to reverse cognitive loss can easily be conducted in the following fields: Alzheimer’s Disease, age-related memory loss, depression, Parkinson’s disease, amyotrophic lateral sclerosis, anesthesia cognitive impairment, autism, cerebral palsy, cystic fibrosis, frontotemporal dementia, Lewy body dementia, mild cognitive impairment, multiple sclerosis, long covid, posttraumatic stress disorder, schizophrenia, systemic lupus, chemotherapy cognitive impairment, and traumatic brain injury.

The purpose of the foundation is to raise funds for these studies and to publish the results in major scientific journals.

Learn More about Olfactory Stimulation and funding FIOS